Clinical-stage biopharmaceutical company
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination (No Activity) |
— | |
| 2025 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | |
| 2025 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | |
| 2025 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | |
| 2024 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination (No Activity) |
— | |
| 2024 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | |
| 2024 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | |
| 2024 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) |
1st Quarter (Jan 1 - Mar 31) Registration |
— |
| Firm | Filings | Expenses |
|---|---|---|
| FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 8 | — |
| Issue | Activities |
|---|---|
| Taxation/Internal Revenue Code | 6 |